0001104659-17-048996.txt : 20170802 0001104659-17-048996.hdr.sgml : 20170802 20170802183034 ACCESSION NUMBER: 0001104659-17-048996 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170731 FILED AS OF DATE: 20170802 DATE AS OF CHANGE: 20170802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bourdow Carrie L. CENTRAL INDEX KEY: 0001638989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 171001608 MAIL ADDRESS: STREET 1: C/O TREVENA, INC. STREET 2: 1018 WEST 8TH AVENUE, SUITE A CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 a4.xml 4 X0306 4 2017-07-31 0 0001641640 Nabriva Therapeutics plc NBRV 0001638989 Bourdow Carrie L. 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 Director Stock Option 2017-07-31 4 A 0 20200 0.00 A 2027-07-31 Ordinary Shares 20200 20200 D The exercise price is Euro 8.94 per share. This option was granted on July 31, 2017. Vesting began on July 31, 2017 and ends on July 31, 2020. This option vests on a monthly pro-rata basis at the end of each successive month following July 31, 2017. /s/ Robert Crotty, by power of attorney 2017-08-02